NASDAQ
Perspective Therapeutics, Inc. (CATX) has a free cash flow growth of -28.90% as of Friday, May 29, 2026. This represents a 1845.48% decrease compared to its 12-month average of 1.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.